Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-06-03

Clinical Trial Update: The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial results evaluating the efficacy and safety of liraglutide as an adjunct to insulin in adults with type 1 diabetes; the study has completed and res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Victoza (Liraglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 3 | Status: COMPLETED | Results posted: 2016-06-03